Skip to main content

Table 1 The yearly RCC patients’ incidence and death estimation in USA

From: Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma

Year

Total RCC cases

Total death

Death rate (%)

References

2021

76,080

13,780

18.1

[4]

2020

73,750

14,830

20.1

[5]

2019

73,820

14,770

20.0

[6]

2018

65,340

14,970

22.9

[7]

2017

63,990

14,400

22.5

[8]

2016

62,700

14,240

22.7

[9]

2015

61,560

14,080

22.9

[10]

2014

63,920

13,860

21.7

[11]

2013

65,150

13,680

21.0

[12]

2012

64,770

13,570

20.8

[13]

2011

60,920

13,120

21.5

[14]

2010

58,240

13,040

22.4

[15]